SkinHealth Systems Inc. (SKIN): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$523.02M
As of 2023-12-31
n/m
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $523.02M | -8.0% | 2024-03-12, Balance as of period end |
| 2022-12-31 | $568.20M | -37.0% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $901.89M | n/m | 2023-03-01, Balance as of period end |
| 2020-12-31 | $9.49M | n/a | 2022-03-01, Balance as of period end |